Connor, Clark & Lunn Investment Management (CC&L)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-279,047
| Closed | -$4.39M | – | 1761 |
|
|
2024
Q1 | $4.39M | Buy |
279,047
+27,902
| +11% | +$439K | 0.02% | 463 |
|
|
2023
Q4 | $4.05M | Buy |
251,145
+178,973
| +248% | +$2.89M | 0.02% | 489 |
|
|
2023
Q3 | $918K | Buy |
72,172
+6,296
| +10% | +$80.1K | ﹤0.01% | 846 |
|
|
2023
Q2 | $928K | Buy |
65,876
+49,989
| +315% | +$704K | ﹤0.01% | 816 |
|
|
2023
Q1 | $245K | Buy |
+15,887
| New | +$245K | ﹤0.01% | 1050 |
|
|
2022
Q2 | – | Sell |
-89,885
| Closed | -$833K | – | 1228 |
|
|
2022
Q1 | $833K | Buy |
89,885
+52,757
| +142% | +$489K | ﹤0.01% | 695 |
|
|
2021
Q4 | $363K | Buy |
+37,128
| New | +$363K | ﹤0.01% | 864 |
|